Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | SCP2 | P22307 | 1/20 | 0.47 |
| ▸ | PTPRA | P18433 | 1/20 | 0.43 |
| ▸ | PTPRB | P23467 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL62448 | 0.86 | MEN1 (0.69) | MEN1NPC1POLBRAB9AKMT2A | |
| SCHEMBL62437 | 0.85 | MEN1 (0.59) | MEN1NPC1POLBRAB9AKMT2A | |
| SCHEMBL13201657 | 0.84 | MEN1 (0.58) | MEN1NPC1POLBRAB9AKMT2A | |
| SCHEMBL8858355 | 0.82 | NPC1 (0.76) | MEN1NPC1POLBRAB9AKMT2A | |
| SCHEMBL13182571 | 0.80 | MEN1 (0.60) | MEN1NPC1POLBRAB9AKMT2A | |
| Nile Red SCHEMBL49047 | 0.79 | MEN1 (1.00) | MEN1NPC1POLBRAB9AKMT2A | |
| Nile Red SCHEMBL29373685 | 0.79 | MEN1 (1.00) | MEN1NPC1POLBRAB9AKMT2A | |
| SCHEMBL23373808 | 0.77 | RAB9A (0.56) | MEN1NPC1POLBRAB9AKMT2A | |
| SCHEMBL31722939 | 0.77 | NPC1 (0.74) | MEN1NPC1POLBRAB9AKMT2A | |
| SCHEMBL14986327 | 0.77 | NPC1 (0.74) | MEN1NPC1POLBRAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147932-A1 | FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147932-A1 | FLUORESCENT PROBES FOR QUANTIFICATION OF DNA DAMAGE AND REPAIR | UNG, OGG1, FEN1 | MEN1 4141/4885NPC1 2637/4885POLB 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.